RU2378275C2 - ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-c]ПИРИДИНА И СПОСОБ ИХ ПОЛУЧЕНИЯ - Google Patents
ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-c]ПИРИДИНА И СПОСОБ ИХ ПОЛУЧЕНИЯ Download PDFInfo
- Publication number
- RU2378275C2 RU2378275C2 RU2007112108/04A RU2007112108A RU2378275C2 RU 2378275 C2 RU2378275 C2 RU 2378275C2 RU 2007112108/04 A RU2007112108/04 A RU 2007112108/04A RU 2007112108 A RU2007112108 A RU 2007112108A RU 2378275 C2 RU2378275 C2 RU 2378275C2
- Authority
- RU
- Russia
- Prior art keywords
- pyrrolo
- pyridine hydrochloride
- tetrahydroisoquinolin
- dimethyl
- benzyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- SRSKXJVMVSSSHB-UHFFFAOYSA-N 1h-pyrrolo[3,2-c]pyridine Chemical class N1=CC=C2NC=CC2=C1 SRSKXJVMVSSSHB-UHFFFAOYSA-N 0.000 title abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 133
- 150000003839 salts Chemical class 0.000 claims abstract description 32
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 27
- 150000002367 halogens Chemical class 0.000 claims abstract description 27
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 17
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 17
- 239000001257 hydrogen Substances 0.000 claims abstract description 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 15
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 claims abstract description 14
- 108010083204 Proton Pumps Proteins 0.000 claims abstract description 14
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract description 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract description 8
- 125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims abstract description 5
- JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims abstract description 5
- 125000003277 amino group Chemical group 0.000 claims abstract description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 5
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims abstract description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 5
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- 125000006678 phenoxycarbonyl group Chemical group 0.000 claims abstract description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 3
- -1 methoxy, ethoxy, hydroxy, cyclopropyl Chemical group 0.000 claims description 42
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 25
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims description 19
- 125000001424 substituent group Chemical group 0.000 claims description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- MOBFKMKSMVCGIL-UHFFFAOYSA-N 2-(2,3-dimethyl-1h-pyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline Chemical compound C1CC2=CC=CC=C2CN1C1=C(C(=C(C)N2)C)C2=CC=N1 MOBFKMKSMVCGIL-UHFFFAOYSA-N 0.000 claims description 8
- ATSWNTFZKGWYLK-UHFFFAOYSA-N 2-(3-benzyl-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline Chemical compound CC=1NC2=CC=NC(N3CC4=CC=CC=C4CC3)=C2C=1CC1=CC=CC=C1 ATSWNTFZKGWYLK-UHFFFAOYSA-N 0.000 claims description 7
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims description 7
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 6
- OEOMIDTXZSSTSD-UHFFFAOYSA-N 2-(3-benzyl-1,2-dimethylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(C)C(C)=C1CC1=CC=CC=C1 OEOMIDTXZSSTSD-UHFFFAOYSA-N 0.000 claims description 6
- QHDOWYKPOXJIRN-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2,3-dimethyl-1h-pyrrolo[3,2-c]pyridin-4-amine Chemical compound C=12C(C)=C(C)NC2=CC=NC=1NCC1=CC=C(F)C=C1 QHDOWYKPOXJIRN-UHFFFAOYSA-N 0.000 claims description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 6
- MJRMTVJPUKCMGP-UHFFFAOYSA-N 2-(1,2,3-trimethylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(C)C2=CC=N1 MJRMTVJPUKCMGP-UHFFFAOYSA-N 0.000 claims description 5
- FNKNNAYPNBVIHP-UHFFFAOYSA-N 2-(1-ethyl-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CC)C2=CC=N1 FNKNNAYPNBVIHP-UHFFFAOYSA-N 0.000 claims description 5
- AAHYNRGBVRQBQJ-UHFFFAOYSA-N 2-(2,3-dimethyl-1h-pyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C(C(=C(C)N2)C)C2=CC=N1 AAHYNRGBVRQBQJ-UHFFFAOYSA-N 0.000 claims description 5
- YVYRCUVPCHNUFB-UHFFFAOYSA-N 2-(3-benzyl-1-cyclopropyl-2-methylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(C2CC2)C(C)=C1CC1=CC=CC=C1 YVYRCUVPCHNUFB-UHFFFAOYSA-N 0.000 claims description 5
- SUZWTGHMJHSJBH-UHFFFAOYSA-N 2-(3-benzyl-1-ethyl-2-methylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC)C(C)=C1CC1=CC=CC=C1 SUZWTGHMJHSJBH-UHFFFAOYSA-N 0.000 claims description 5
- DTTRXKDZDKKEIO-UHFFFAOYSA-N 2-(3-benzyl-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC=1NC2=CC=NC(N3CC4=CC=CC=C4CC3)=C2C=1CC1=CC=CC=C1 DTTRXKDZDKKEIO-UHFFFAOYSA-N 0.000 claims description 5
- SCJSSLOKGQNGGO-UHFFFAOYSA-N 2-[1-(2-methoxyethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CCOC)C2=CC=N1 SCJSSLOKGQNGGO-UHFFFAOYSA-N 0.000 claims description 5
- KQXZEOVZQMUYFG-UHFFFAOYSA-N 2-[4-(3,4-dihydro-1h-isoquinolin-2-yl)-2,3-dimethylpyrrolo[3,2-c]pyridin-1-yl]ethanol;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CCO)C2=CC=N1 KQXZEOVZQMUYFG-UHFFFAOYSA-N 0.000 claims description 5
- ACARDXIEVWECPE-UHFFFAOYSA-N 3-benzyl-n-[(4-fluorophenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1NCC1=CC=C(F)C=C1 ACARDXIEVWECPE-UHFFFAOYSA-N 0.000 claims description 5
- VUEXVEYRULCKDR-UHFFFAOYSA-N 2-(1,3-dibenzyl-2-methylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC=2C=CC=CC=2)C(C)=C1CC1=CC=CC=C1 VUEXVEYRULCKDR-UHFFFAOYSA-N 0.000 claims description 4
- ONOWUWTYEPDOEH-UHFFFAOYSA-N 2-(3-benzyl-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;sodium Chemical compound [Na].CC=1NC2=CC=NC(N3CC4=CC=CC=C4CC3)=C2C=1CC1=CC=CC=C1 ONOWUWTYEPDOEH-UHFFFAOYSA-N 0.000 claims description 4
- GIGDJMYLGIFAMI-UHFFFAOYSA-N 2-[3-benzyl-1-(2-methoxyethyl)-2-methylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CCOC)C(C)=C1CC1=CC=CC=C1 GIGDJMYLGIFAMI-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- FTOKAERMHAZEBC-UHFFFAOYSA-N 1-(1,3-dioxolan-2-ylmethyl)-n-[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC3OCCO3)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 FTOKAERMHAZEBC-UHFFFAOYSA-N 0.000 claims description 3
- GIYBOSFIQTZHFE-UHFFFAOYSA-N 1-(cyclopropylmethyl)-n-[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC3CC3)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 GIYBOSFIQTZHFE-UHFFFAOYSA-N 0.000 claims description 3
- MPHMNJXBNQRNFZ-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-n-[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC=3C(=CC=CC=3)F)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 MPHMNJXBNQRNFZ-UHFFFAOYSA-N 0.000 claims description 3
- GKVWBVIAZSLRSS-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-n-[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC=3C=C(F)C=CC=3)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 GKVWBVIAZSLRSS-UHFFFAOYSA-N 0.000 claims description 3
- ZOEGPHVJGFFOEC-UHFFFAOYSA-N 1-ethyl-n-[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 ZOEGPHVJGFFOEC-UHFFFAOYSA-N 0.000 claims description 3
- BJJHMXUCZVIMSD-UHFFFAOYSA-N 2-(1-cyclopentyl-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1C1CCCC1 BJJHMXUCZVIMSD-UHFFFAOYSA-N 0.000 claims description 3
- OJEPWYSVIWHLDT-UHFFFAOYSA-N 2-(1-cyclopropyl-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1C1CC1 OJEPWYSVIWHLDT-UHFFFAOYSA-N 0.000 claims description 3
- WUUCCRRUHJKPHU-UHFFFAOYSA-N 2-(2,3-dimethyl-1-pent-4-ynylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CCCC#C)C2=CC=N1 WUUCCRRUHJKPHU-UHFFFAOYSA-N 0.000 claims description 3
- UCJXYUIAWKAIMS-UHFFFAOYSA-N 2-(2,3-dimethyl-1-propan-2-ylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(C(C)C)C2=CC=N1 UCJXYUIAWKAIMS-UHFFFAOYSA-N 0.000 claims description 3
- XPFICLZDEQEYSC-UHFFFAOYSA-N 2-(3-benzyl-2-methyl-1-propylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CCC)C(C)=C1CC1=CC=CC=C1 XPFICLZDEQEYSC-UHFFFAOYSA-N 0.000 claims description 3
- ULIVDDMSKBPNFG-UHFFFAOYSA-N 2-[1-(2-ethoxyethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CCOCC)C2=CC=N1 ULIVDDMSKBPNFG-UHFFFAOYSA-N 0.000 claims description 3
- QSDQLVDRCBMYTA-UHFFFAOYSA-N 2-[1-(2-methoxyethoxymethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(COCCOC)C2=CC=N1 QSDQLVDRCBMYTA-UHFFFAOYSA-N 0.000 claims description 3
- CRAZBLOQGMPAHT-UHFFFAOYSA-N 2-[1-(cyclobutylmethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1CCC1 CRAZBLOQGMPAHT-UHFFFAOYSA-N 0.000 claims description 3
- YQJBTJAHVSOJMN-UHFFFAOYSA-N 2-[1-(cyclohexylmethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1CCCCC1 YQJBTJAHVSOJMN-UHFFFAOYSA-N 0.000 claims description 3
- REFOYKQHOFLXHO-UHFFFAOYSA-N 2-[1-(cyclopropylmethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1CC1 REFOYKQHOFLXHO-UHFFFAOYSA-N 0.000 claims description 3
- ZTOWOKXCLUVSRW-UHFFFAOYSA-N 2-[1-(methoxymethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(COC)C2=CC=N1 ZTOWOKXCLUVSRW-UHFFFAOYSA-N 0.000 claims description 3
- BFOZFIJJUBUVKA-UHFFFAOYSA-N 2-[1-[(2-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1=CC=CC=C1F BFOZFIJJUBUVKA-UHFFFAOYSA-N 0.000 claims description 3
- POAXXYVFPYOZAG-UHFFFAOYSA-N 2-[1-[(3-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1=CC=CC(F)=C1 POAXXYVFPYOZAG-UHFFFAOYSA-N 0.000 claims description 3
- NPNPNKFEFQBAJM-UHFFFAOYSA-N 2-[1-[(4-chlorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1=CC=C(Cl)C=C1 NPNPNKFEFQBAJM-UHFFFAOYSA-N 0.000 claims description 3
- RLIYRUAPVFXNHE-UHFFFAOYSA-N 2-[1-[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1=CC=C(F)C=C1 RLIYRUAPVFXNHE-UHFFFAOYSA-N 0.000 claims description 3
- ORWOJQAEHRBSOB-UHFFFAOYSA-N 2-[2,3-dimethyl-1-(2-methylpropyl)pyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CC(C)C)C2=CC=N1 ORWOJQAEHRBSOB-UHFFFAOYSA-N 0.000 claims description 3
- UJCYOUFQWXNCEJ-UHFFFAOYSA-N 2-[2,3-dimethyl-1-(3-methylbutyl)pyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CCC(C)C)C2=CC=N1 UJCYOUFQWXNCEJ-UHFFFAOYSA-N 0.000 claims description 3
- BXINHQKPEDPVGU-UHFFFAOYSA-N 2-[2,3-dimethyl-1-[(4-methylphenyl)methyl]pyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1=CC=C(C)C=C1 BXINHQKPEDPVGU-UHFFFAOYSA-N 0.000 claims description 3
- DQZGPBWETXUNNI-UHFFFAOYSA-N 2-[3-[(3-fluorophenyl)methyl]-1,2-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(C)C(C)=C1CC1=CC=CC(F)=C1 DQZGPBWETXUNNI-UHFFFAOYSA-N 0.000 claims description 3
- KOBAQPXFDCHUEF-UHFFFAOYSA-N 2-[3-[(3-fluorophenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC=1NC2=CC=NC(N3CC4=CC=CC=C4CC3)=C2C=1CC1=CC=CC(F)=C1 KOBAQPXFDCHUEF-UHFFFAOYSA-N 0.000 claims description 3
- LOKJNFNRDILBPD-UHFFFAOYSA-N 2-[3-benzyl-1-(cyclopropylmethyl)-2-methylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC2CC2)C(C)=C1CC1=CC=CC=C1 LOKJNFNRDILBPD-UHFFFAOYSA-N 0.000 claims description 3
- PVDAYZWIUSGBCG-UHFFFAOYSA-N 2-[3-benzyl-1-[(2-fluorophenyl)methyl]-2-methylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC=2C(=CC=CC=2)F)C(C)=C1CC1=CC=CC=C1 PVDAYZWIUSGBCG-UHFFFAOYSA-N 0.000 claims description 3
- XCCZHTWPFSPKDW-UHFFFAOYSA-N 2-[3-benzyl-1-[(3-fluorophenyl)methyl]-2-methylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC=2C=C(F)C=CC=2)C(C)=C1CC1=CC=CC=C1 XCCZHTWPFSPKDW-UHFFFAOYSA-N 0.000 claims description 3
- HIYFFQBYVOJEBX-UHFFFAOYSA-N 2-[3-benzyl-1-[(4-fluorophenyl)methyl]-2-methylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC=2C=CC(F)=CC=2)C(C)=C1CC1=CC=CC=C1 HIYFFQBYVOJEBX-UHFFFAOYSA-N 0.000 claims description 3
- ZUJHLNPTEJJPFV-UHFFFAOYSA-N 2-[3-benzyl-2-methyl-1-(2-methylpropyl)pyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC(C)C)C(C)=C1CC1=CC=CC=C1 ZUJHLNPTEJJPFV-UHFFFAOYSA-N 0.000 claims description 3
- WTPQWYUHOUTNGV-UHFFFAOYSA-N 2-[3-benzyl-4-(3,4-dihydro-1h-isoquinolin-2-yl)-2-methylpyrrolo[3,2-c]pyridin-1-yl]ethanol;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CCO)C(C)=C1CC1=CC=CC=C1 WTPQWYUHOUTNGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000003541 2-chlorobenzoyl group Chemical group ClC1=C(C(=O)*)C=CC=C1 0.000 claims description 3
- IGXPLJHCYYMNGY-UHFFFAOYSA-N 3-benzyl-4-[(4-chlorophenyl)methoxy]-1,2-dimethylpyrrolo[3,2-c]pyridine;hydrochloride Chemical compound Cl.C12=C(OCC=3C=CC(Cl)=CC=3)N=CC=C2N(C)C(C)=C1CC1=CC=CC=C1 IGXPLJHCYYMNGY-UHFFFAOYSA-N 0.000 claims description 3
- IFSKHAYJVODUGI-UHFFFAOYSA-N 3-benzyl-4-[(4-chlorophenyl)methoxy]-2-methyl-1h-pyrrolo[3,2-c]pyridine;hydrochloride Chemical compound Cl.C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1OCC1=CC=C(Cl)C=C1 IFSKHAYJVODUGI-UHFFFAOYSA-N 0.000 claims description 3
- TWZYKCGVRKVCDJ-UHFFFAOYSA-N 3-benzyl-4-[(4-fluorophenyl)methoxy]-1,2-dimethylpyrrolo[3,2-c]pyridine;hydrochloride Chemical compound Cl.C12=C(OCC=3C=CC(F)=CC=3)N=CC=C2N(C)C(C)=C1CC1=CC=CC=C1 TWZYKCGVRKVCDJ-UHFFFAOYSA-N 0.000 claims description 3
- CFFNYRZQQAOAAQ-UHFFFAOYSA-N 3-benzyl-4-[(4-fluorophenyl)methoxy]-2-methyl-1h-pyrrolo[3,2-c]pyridine;hydrochloride Chemical compound Cl.C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1OCC1=CC=C(F)C=C1 CFFNYRZQQAOAAQ-UHFFFAOYSA-N 0.000 claims description 3
- WZZXRAMVBFGMIA-UHFFFAOYSA-N 3-benzyl-n-[(4-chlorophenyl)methyl]-1,2-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.C12=C(NCC=3C=CC(Cl)=CC=3)N=CC=C2N(C)C(C)=C1CC1=CC=CC=C1 WZZXRAMVBFGMIA-UHFFFAOYSA-N 0.000 claims description 3
- XXZGARIBQQPDJU-UHFFFAOYSA-N 3-benzyl-n-[(4-chlorophenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1NCC1=CC=C(Cl)C=C1 XXZGARIBQQPDJU-UHFFFAOYSA-N 0.000 claims description 3
- QTDYHTIJYCGHTG-UHFFFAOYSA-N 3-benzyl-n-[(4-fluorophenyl)methyl]-1,2-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.C12=C(NCC=3C=CC(F)=CC=3)N=CC=C2N(C)C(C)=C1CC1=CC=CC=C1 QTDYHTIJYCGHTG-UHFFFAOYSA-N 0.000 claims description 3
- 230000002140 halogenating effect Effects 0.000 claims description 3
- SJEHVDXAMXZVNO-UHFFFAOYSA-N n,1-bis[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC=3C=CC(F)=CC=3)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 SJEHVDXAMXZVNO-UHFFFAOYSA-N 0.000 claims description 3
- LNNUNEYNSXYDHY-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-1,2,3-trimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(C)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 LNNUNEYNSXYDHY-UHFFFAOYSA-N 0.000 claims description 3
- AEYNVCKVLACMGT-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-1-(2-methoxyethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CCOC)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 AEYNVCKVLACMGT-UHFFFAOYSA-N 0.000 claims description 3
- BLCYASBLTZZFLJ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2,3-dimethyl-1-(2-methylpropyl)pyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC(C)C)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 BLCYASBLTZZFLJ-UHFFFAOYSA-N 0.000 claims description 3
- JZTSVXBCKAARGM-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2,3-dimethyl-1-propan-2-ylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(C(C)C)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 JZTSVXBCKAARGM-UHFFFAOYSA-N 0.000 claims description 3
- KJRXJVDRIGNKSN-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2,3-dimethyl-1-propylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CCC)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 KJRXJVDRIGNKSN-UHFFFAOYSA-N 0.000 claims description 3
- NNQCAVXWNUKSPR-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2,3-dimethyl-1h-pyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.C=12C(C)=C(C)NC2=CC=NC=1NCC1=CC=C(F)C=C1 NNQCAVXWNUKSPR-UHFFFAOYSA-N 0.000 claims description 3
- 238000007363 ring formation reaction Methods 0.000 claims description 3
- 235000010288 sodium nitrite Nutrition 0.000 claims description 3
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims description 3
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 claims description 2
- GZQKLLZFBUXQTC-UHFFFAOYSA-N 2-(1-butyl-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CCCC)C2=CC=N1 GZQKLLZFBUXQTC-UHFFFAOYSA-N 0.000 claims description 2
- GUIMTACSGGQDMX-UHFFFAOYSA-N 2-[2,3-dimethyl-1-(3-methylbut-2-enyl)pyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CC=C(C)C)C2=CC=N1 GUIMTACSGGQDMX-UHFFFAOYSA-N 0.000 claims description 2
- HPYHQVUHWZPMMV-UHFFFAOYSA-N 4-[[4-(3,4-dihydro-1h-isoquinolin-2-yl)-2,3-dimethylpyrrolo[3,2-c]pyridin-1-yl]methyl]-2-methyl-1,3-thiazole;hydrochloride Chemical compound Cl.S1C(C)=NC(CN2C3=CC=NC(=C3C(C)=C2C)N2CC3=CC=CC=C3CC2)=C1 HPYHQVUHWZPMMV-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- XVJRFYVHQMPDMJ-UHFFFAOYSA-N n,n-bis[(4-fluorophenyl)methyl]-1,2,3-trimethylpyrrolo[3,2-c]pyridin-7-amine;hydrochloride Chemical compound Cl.C=12N(C)C(C)=C(C)C2=CN=CC=1N(CC=1C=CC(F)=CC=1)CC1=CC=C(F)C=C1 XVJRFYVHQMPDMJ-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 230000002441 reversible effect Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 93
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 84
- 239000011541 reaction mixture Substances 0.000 description 48
- 239000007787 solid Substances 0.000 description 40
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- 238000002360 preparation method Methods 0.000 description 29
- 239000000243 solution Substances 0.000 description 28
- 238000012360 testing method Methods 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- 229920006395 saturated elastomer Polymers 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 15
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 12
- 229910000104 sodium hydride Inorganic materials 0.000 description 12
- 239000012312 sodium hydride Substances 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 9
- 230000002496 gastric effect Effects 0.000 description 9
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 8
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- GXVWAMRQIVPEAS-UHFFFAOYSA-N 3-benzyl-4-chloro-2-methyl-1h-pyrrolo[3,2-c]pyridine Chemical compound CC=1NC2=CC=NC(Cl)=C2C=1CC1=CC=CC=C1 GXVWAMRQIVPEAS-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- ICQHVQJVRZINSO-UHFFFAOYSA-N 4-hydrazinyl-1h-pyridin-2-one Chemical compound NNC=1C=CNC(=O)C=1 ICQHVQJVRZINSO-UHFFFAOYSA-N 0.000 description 5
- 210000004211 gastric acid Anatomy 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- XPPGLZUUYITAQM-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-1,2,3-trimethylpyrrolo[3,2-c]pyridin-4-amine Chemical compound N1=CC=C2N(C)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 XPPGLZUUYITAQM-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 210000001187 pylorus Anatomy 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- WPJWHKZVPLCYFL-UHFFFAOYSA-N 4-chloro-2,3-dimethyl-1h-pyrrolo[3,2-c]pyridine Chemical compound C1=NC(Cl)=C2C(C)=C(C)NC2=C1 WPJWHKZVPLCYFL-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 4
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 description 4
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940126409 proton pump inhibitor Drugs 0.000 description 4
- 239000000612 proton pump inhibitor Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- NVNPLEPBDPJYRZ-UHFFFAOYSA-N 1-(bromomethyl)-4-fluorobenzene Chemical compound FC1=CC=C(CBr)C=C1 NVNPLEPBDPJYRZ-UHFFFAOYSA-N 0.000 description 3
- YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 3
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 3
- CKIIJIDEWWXQEA-UHFFFAOYSA-N 2-(bromomethyl)-1,3-dioxolane Chemical compound BrCC1OCCO1 CKIIJIDEWWXQEA-UHFFFAOYSA-N 0.000 description 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 3
- 108091006112 ATPases Proteins 0.000 description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 3
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 229960000381 omeprazole Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 230000006965 reversible inhibition Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N (4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1 IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 2
- SCBZBMXPJYMXRC-UHFFFAOYSA-N 1-(bromomethyl)-3-fluorobenzene Chemical compound FC1=CC=CC(CBr)=C1 SCBZBMXPJYMXRC-UHFFFAOYSA-N 0.000 description 2
- VQVGQEICCSENSO-UHFFFAOYSA-N 1-benzyl-n-[(4-fluorophenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-amine;hydrochloride Chemical compound Cl.N1=CC=C2N(CC=3C=CC=CC=3)C(C)=C(C)C2=C1NCC1=CC=C(F)C=C1 VQVGQEICCSENSO-UHFFFAOYSA-N 0.000 description 2
- LZSKSZSVTVXZLO-UHFFFAOYSA-N 2,3-dimethyl-1,5-dihydropyrrolo[3,2-c]pyridin-4-one Chemical compound C1=CNC(=O)C2=C1NC(C)=C2C LZSKSZSVTVXZLO-UHFFFAOYSA-N 0.000 description 2
- MVFHHOJYASQLPF-UHFFFAOYSA-N 2-(1-benzyl-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1=CC=CC=C1 MVFHHOJYASQLPF-UHFFFAOYSA-N 0.000 description 2
- MWRWLDBOALQLJR-UHFFFAOYSA-N 2-(2,3-dimethyl-1-propylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2CN1C1=C2C(C)=C(C)N(CCC)C2=CC=N1 MWRWLDBOALQLJR-UHFFFAOYSA-N 0.000 description 2
- NIGKAPPVDZFFRK-UHFFFAOYSA-N 2-[1-[(4-methoxyphenyl)methyl]-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CN1C2=CC=NC(N3CC4=CC=CC=C4CC3)=C2C(C)=C1C NIGKAPPVDZFFRK-UHFFFAOYSA-N 0.000 description 2
- HSSIAIYLHPIUPQ-UHFFFAOYSA-N 2-[3-[(3-fluorophenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline Chemical compound CC=1NC2=CC=NC(N3CC4=CC=CC=C4CC3)=C2C=1CC1=CC=CC(F)=C1 HSSIAIYLHPIUPQ-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 2
- DDTOMSRCLVWZGM-UHFFFAOYSA-N 3-[(3-fluorophenyl)methyl]-2-methyl-1,5-dihydropyrrolo[3,2-c]pyridin-4-one Chemical compound CC=1NC=2C=CNC(=O)C=2C=1CC1=CC=CC(F)=C1 DDTOMSRCLVWZGM-UHFFFAOYSA-N 0.000 description 2
- LXZISLCBZNSSRV-UHFFFAOYSA-N 3-benzyl-2-methyl-1,5-dihydropyrrolo[3,2-c]pyridin-4-one Chemical compound CC=1NC=2C=CNC(=O)C=2C=1CC1=CC=CC=C1 LXZISLCBZNSSRV-UHFFFAOYSA-N 0.000 description 2
- LLUPBWKKGFPVFB-UHFFFAOYSA-N 3-benzyl-4-[(4-chlorophenyl)methoxy]-2-methyl-1h-pyrrolo[3,2-c]pyridine Chemical compound C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1OCC1=CC=C(Cl)C=C1 LLUPBWKKGFPVFB-UHFFFAOYSA-N 0.000 description 2
- ZXVXRPJEPIKDKP-UHFFFAOYSA-N 3-benzyl-4-[(4-fluorophenyl)methoxy]-2-methyl-1h-pyrrolo[3,2-c]pyridine Chemical compound C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1OCC1=CC=C(F)C=C1 ZXVXRPJEPIKDKP-UHFFFAOYSA-N 0.000 description 2
- WWUYPIBQWXDLOF-UHFFFAOYSA-N 3-benzyl-n-[(4-chlorophenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-amine Chemical compound C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1NCC1=CC=C(Cl)C=C1 WWUYPIBQWXDLOF-UHFFFAOYSA-N 0.000 description 2
- AEOQFPURRSKNMP-UHFFFAOYSA-N 3-benzyl-n-[(4-fluorophenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridin-4-amine Chemical compound C=12C(CC=3C=CC=CC=3)=C(C)NC2=CC=NC=1NCC1=CC=C(F)C=C1 AEOQFPURRSKNMP-UHFFFAOYSA-N 0.000 description 2
- FPIOMQOKSDIROB-UHFFFAOYSA-N 4-(2-butan-2-ylidenehydrazinyl)-1h-pyridin-2-one Chemical compound CCC(C)=NNC=1C=CNC(=O)C=1 FPIOMQOKSDIROB-UHFFFAOYSA-N 0.000 description 2
- AZAPZQDVFYTHIM-UHFFFAOYSA-N 4-[2-(4-phenylbutan-2-ylidene)hydrazinyl]-1h-pyridin-2-one Chemical compound C1=CNC(=O)C=C1NN=C(C)CCC1=CC=CC=C1 AZAPZQDVFYTHIM-UHFFFAOYSA-N 0.000 description 2
- RPAWBFGNACVCDM-UHFFFAOYSA-N 4-[2-[4-(3-fluorophenyl)butan-2-ylidene]hydrazinyl]-1h-pyridin-2-one Chemical compound C1=CNC(=O)C=C1NN=C(C)CCC1=CC=CC(F)=C1 RPAWBFGNACVCDM-UHFFFAOYSA-N 0.000 description 2
- VQJJRCUDOUEYAP-UHFFFAOYSA-N 4-chloro-3-[(3-fluorophenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridine Chemical compound CC=1NC2=CC=NC(Cl)=C2C=1CC1=CC=CC(F)=C1 VQJJRCUDOUEYAP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 2
- LKXYJYDRLBPHRS-UHFFFAOYSA-N bromocyclopropane Chemical compound BrC1CC1 LKXYJYDRLBPHRS-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- YMVFJGSXZNNUDW-UHFFFAOYSA-N (4-chlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1 YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
- PTHGDVCPCZKZKR-UHFFFAOYSA-N (4-chlorophenyl)methanol Chemical compound OCC1=CC=C(Cl)C=C1 PTHGDVCPCZKZKR-UHFFFAOYSA-N 0.000 description 1
- GEZMEIHVFSWOCA-UHFFFAOYSA-N (4-fluorophenyl)methanol Chemical compound OCC1=CC=C(F)C=C1 GEZMEIHVFSWOCA-UHFFFAOYSA-N 0.000 description 1
- 0 *c1c(*)[n](*)c2c1c(*)ncc2 Chemical compound *c1c(*)[n](*)c2c1c(*)ncc2 0.000 description 1
- FFWQLZFIMNTUCZ-UHFFFAOYSA-N 1-(bromomethyl)-2-fluorobenzene Chemical compound FC1=CC=CC=C1CBr FFWQLZFIMNTUCZ-UHFFFAOYSA-N 0.000 description 1
- BIAAQBNMRITRDV-UHFFFAOYSA-N 1-(chloromethoxy)-2-methoxyethane Chemical compound COCCOCCl BIAAQBNMRITRDV-UHFFFAOYSA-N 0.000 description 1
- MOBRMRJUKNQBMY-UHFFFAOYSA-N 1-(chloromethyl)-2-fluorobenzene Chemical compound FC1=CC=CC=C1CCl MOBRMRJUKNQBMY-UHFFFAOYSA-N 0.000 description 1
- XBDXMDVEZLOGMC-UHFFFAOYSA-N 1-(chloromethyl)-3-fluorobenzene Chemical compound FC1=CC=CC(CCl)=C1 XBDXMDVEZLOGMC-UHFFFAOYSA-N 0.000 description 1
- IZXWCDITFDNEBY-UHFFFAOYSA-N 1-(chloromethyl)-4-fluorobenzene Chemical compound FC1=CC=C(CCl)C=C1 IZXWCDITFDNEBY-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- DMHZDOTYAVHSEH-UHFFFAOYSA-N 1-(chloromethyl)-4-methylbenzene Chemical compound CC1=CC=C(CCl)C=C1 DMHZDOTYAVHSEH-UHFFFAOYSA-N 0.000 description 1
- FOZVXADQAHVUSV-UHFFFAOYSA-N 1-bromo-2-(2-bromoethoxy)ethane Chemical compound BrCCOCCBr FOZVXADQAHVUSV-UHFFFAOYSA-N 0.000 description 1
- LOYZVRIHVZEDMW-UHFFFAOYSA-N 1-bromo-3-methylbut-2-ene Chemical compound CC(C)=CCBr LOYZVRIHVZEDMW-UHFFFAOYSA-N 0.000 description 1
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 1
- JQZAEUFPPSRDOP-UHFFFAOYSA-N 1-chloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1 JQZAEUFPPSRDOP-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- PZLNWHURFHXSTA-UHFFFAOYSA-N 1h-thieno[3,4-d]imidazole Chemical class S1C=C2NC=NC2=C1 PZLNWHURFHXSTA-UHFFFAOYSA-N 0.000 description 1
- ZEZJPIDPVXJEME-UHFFFAOYSA-N 2,4-Dihydroxypyridine Chemical compound OC=1C=CNC(=O)C=1 ZEZJPIDPVXJEME-UHFFFAOYSA-N 0.000 description 1
- HJRCKNXVEUTSNM-UHFFFAOYSA-N 2-(1,3-dibenzyl-2-methylpyrrolo[3,2-c]pyridin-4-yl)-3,4-dihydro-1h-isoquinoline Chemical compound C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC=2C=CC=CC=2)C(C)=C1CC1=CC=CC=C1 HJRCKNXVEUTSNM-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- SZTVQGSQFHDZCG-UHFFFAOYSA-N 2-[1-(1,3-dioxolan-2-ylmethyl)-2,3-dimethylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline Chemical compound CC1=C(C)C2=C(N3CC4=CC=CC=C4CC3)N=CC=C2N1CC1OCCO1 SZTVQGSQFHDZCG-UHFFFAOYSA-N 0.000 description 1
- XRHHCXTUWCAYGB-UHFFFAOYSA-N 2-[3-benzyl-1-(1,3-dioxolan-2-ylmethyl)-2-methylpyrrolo[3,2-c]pyridin-4-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.C12=C(N3CC4=CC=CC=C4CC3)N=CC=C2N(CC2OCCO2)C(C)=C1CC1=CC=CC=C1 XRHHCXTUWCAYGB-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 description 1
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- RMEPWLSRADQXHY-UHFFFAOYSA-N 4-(2-hex-5-en-2-ylidenehydrazinyl)-1h-pyridin-2-one Chemical compound C=CCCC(C)=NNC=1C=CNC(=O)C=1 RMEPWLSRADQXHY-UHFFFAOYSA-N 0.000 description 1
- IZNPPMHOPRAECP-UHFFFAOYSA-N 4-(3-fluorophenyl)butan-2-one Chemical compound CC(=O)CCC1=CC=CC(F)=C1 IZNPPMHOPRAECP-UHFFFAOYSA-N 0.000 description 1
- DDUFXBYASCLNSR-UHFFFAOYSA-N 4-chloro-3-[fluoro(phenyl)methyl]-2-methyl-1h-pyrrolo[3,2-c]pyridine Chemical compound CC=1NC2=CC=NC(Cl)=C2C=1C(F)C1=CC=CC=C1 DDUFXBYASCLNSR-UHFFFAOYSA-N 0.000 description 1
- RNDVGJZUHCKENF-UHFFFAOYSA-N 5-hexen-2-one Chemical compound CC(=O)CCC=C RNDVGJZUHCKENF-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000017189 Gastrointestinal inflammatory disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 108010067973 Valinomycin Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000362 adenosine triphosphatase inhibitor Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001262 anti-secretory effect Effects 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- JAMFGQBENKSWOF-UHFFFAOYSA-N bromo(methoxy)methane Chemical compound COCBr JAMFGQBENKSWOF-UHFFFAOYSA-N 0.000 description 1
- BRTFVKHPEHKBQF-UHFFFAOYSA-N bromocyclopentane Chemical compound BrC1CCCC1 BRTFVKHPEHKBQF-UHFFFAOYSA-N 0.000 description 1
- UUWSLBWDFJMSFP-UHFFFAOYSA-N bromomethylcyclohexane Chemical compound BrCC1CCCCC1 UUWSLBWDFJMSFP-UHFFFAOYSA-N 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- FCFNRCROJUBPLU-UHFFFAOYSA-N compound M126 Natural products CC(C)C1NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC1=O FCFNRCROJUBPLU-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000001997 free-flow electrophoresis Methods 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 201000000052 gastrinoma Diseases 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 210000001711 oxyntic cell Anatomy 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011546 protein dye Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- FCFNRCROJUBPLU-DNDCDFAISA-N valinomycin Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O FCFNRCROJUBPLU-DNDCDFAISA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20040070536 | 2004-09-03 | ||
| KR10-2004-0070536 | 2004-09-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2007112108A RU2007112108A (ru) | 2008-10-10 |
| RU2378275C2 true RU2378275C2 (ru) | 2010-01-10 |
Family
ID=36000316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007112108/04A RU2378275C2 (ru) | 2004-09-03 | 2005-09-03 | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-c]ПИРИДИНА И СПОСОБ ИХ ПОЛУЧЕНИЯ |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8148529B2 (enExample) |
| EP (1) | EP1784402B1 (enExample) |
| JP (1) | JP5126830B2 (enExample) |
| KR (1) | KR100946219B1 (enExample) |
| CN (1) | CN101018788B (enExample) |
| AT (1) | ATE518858T1 (enExample) |
| AU (1) | AU2005280738B2 (enExample) |
| BR (1) | BRPI0514843A (enExample) |
| CA (1) | CA2578880C (enExample) |
| DK (1) | DK1784402T3 (enExample) |
| ES (1) | ES2367312T3 (enExample) |
| MX (1) | MX2007002214A (enExample) |
| PL (1) | PL1784402T3 (enExample) |
| PT (1) | PT1784402E (enExample) |
| RU (1) | RU2378275C2 (enExample) |
| WO (1) | WO2006025714A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008017466A1 (en) * | 2006-08-08 | 2008-02-14 | Nycomed Gmbh | Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
| EP2452680B1 (en) | 2009-07-09 | 2019-12-18 | RaQualia Pharma Inc. | Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility |
| TWI636047B (zh) | 2013-08-14 | 2018-09-21 | 英商卡爾維斯塔製藥有限公司 | 雜環衍生物 |
| GB2517908A (en) * | 2013-08-14 | 2015-03-11 | Kalvista Pharmaceuticals Ltd | Bicyclic inhibitors |
| CN103626767A (zh) * | 2013-12-04 | 2014-03-12 | 上海药明康德新药开发有限公司 | 区域选择性的氮杂吲哚及其合成方法 |
| GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
| MA46427A (fr) | 2015-10-09 | 2018-08-15 | Wave Life Sciences Ltd | Compositions d'oligonucléotides et procédés associés |
| ME03794B (me) | 2016-05-31 | 2021-04-20 | Kalvista Pharmaceuticals Ltd | Derivati pirazola kao inhibitori kalikreina plazme |
| GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
| GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
| PL3716952T3 (pl) | 2017-11-29 | 2022-05-02 | Kalvista Pharmaceuticals Limited | Postacie dawkowania zawierające inhibitor kalikreiny osoczowej |
| WO2021028645A1 (en) | 2019-08-09 | 2021-02-18 | Kalvista Pharmaceuticals Limited | Plasma kallikrein inhibitors |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2135497C1 (ru) * | 1993-11-17 | 1999-08-27 | Зенека Лимитед | Пирролопиридины или их сельскохозяйственно-приемлемые соли, гербицидная композиция и способ подавления нежелательной растительности |
| WO2003009852A1 (en) * | 2001-07-24 | 2003-02-06 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0068378B1 (en) | 1981-06-26 | 1986-03-05 | Schering Corporation | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| JP3465827B2 (ja) * | 1993-02-24 | 2003-11-10 | 株式会社日清製粉グループ本社 | アザインドール誘導体およびこれを有効成分とする抗潰瘍薬 |
| HU225920B1 (en) * | 1994-01-19 | 2008-01-28 | Sankyo Co | Pyrrolo[2,3-d]pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| EP0775120B1 (en) | 1994-08-13 | 2003-06-04 | Yuhan Corporation | Novel pyrimidine derivatives and processes for the preparation thereof |
| EP0849274A1 (en) * | 1996-12-20 | 1998-06-24 | Schering Aktiengesellschaft | Bissteroidal compounds and their use for the preparation of chiral complexes |
| SE9700661D0 (sv) | 1997-02-25 | 1997-02-25 | Astra Ab | New compounds |
| SE9704404D0 (sv) * | 1997-11-28 | 1997-11-28 | Astra Ab | New compounds |
| YU47600A (sh) * | 1998-01-27 | 2002-09-19 | Aventis Pharmaceuticals Products Inc. | SUPSTITUISANI OKSOAZAHETEROCIKLIL INHIBITORI FAKTORA Xa |
| WO2000017200A1 (en) | 1998-09-23 | 2000-03-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
-
2005
- 2005-09-03 DK DK05781131.7T patent/DK1784402T3/da active
- 2005-09-03 BR BRPI0514843-0A patent/BRPI0514843A/pt not_active Application Discontinuation
- 2005-09-03 ES ES05781131T patent/ES2367312T3/es not_active Expired - Lifetime
- 2005-09-03 PT PT05781131T patent/PT1784402E/pt unknown
- 2005-09-03 MX MX2007002214A patent/MX2007002214A/es active IP Right Grant
- 2005-09-03 WO PCT/KR2005/002924 patent/WO2006025714A1/en not_active Ceased
- 2005-09-03 AU AU2005280738A patent/AU2005280738B2/en not_active Ceased
- 2005-09-03 AT AT05781131T patent/ATE518858T1/de active
- 2005-09-03 JP JP2007529714A patent/JP5126830B2/ja not_active Expired - Fee Related
- 2005-09-03 RU RU2007112108/04A patent/RU2378275C2/ru not_active IP Right Cessation
- 2005-09-03 PL PL05781131T patent/PL1784402T3/pl unknown
- 2005-09-03 KR KR1020050082008A patent/KR100946219B1/ko not_active Expired - Fee Related
- 2005-09-03 CN CN200580029382XA patent/CN101018788B/zh not_active Expired - Fee Related
- 2005-09-03 CA CA2578880A patent/CA2578880C/en not_active Expired - Fee Related
- 2005-09-03 US US11/574,393 patent/US8148529B2/en not_active Expired - Fee Related
- 2005-09-03 EP EP05781131A patent/EP1784402B1/en not_active Expired - Lifetime
-
2011
- 2011-11-15 US US13/296,378 patent/US8513277B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2135497C1 (ru) * | 1993-11-17 | 1999-08-27 | Зенека Лимитед | Пирролопиридины или их сельскохозяйственно-приемлемые соли, гербицидная композиция и способ подавления нежелательной растительности |
| WO2003009852A1 (en) * | 2001-07-24 | 2003-02-06 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
Non-Patent Citations (1)
Also Published As
| Publication number | Publication date |
|---|---|
| EP1784402A4 (en) | 2009-12-23 |
| PT1784402E (pt) | 2011-08-23 |
| ATE518858T1 (de) | 2011-08-15 |
| AU2005280738A1 (en) | 2006-03-09 |
| RU2007112108A (ru) | 2008-10-10 |
| EP1784402A1 (en) | 2007-05-16 |
| CN101018788A (zh) | 2007-08-15 |
| US20120065224A1 (en) | 2012-03-15 |
| CA2578880A1 (en) | 2006-03-09 |
| US8513277B2 (en) | 2013-08-20 |
| HK1105977A1 (en) | 2008-02-29 |
| KR100946219B1 (ko) | 2010-03-08 |
| JP2008511618A (ja) | 2008-04-17 |
| EP1784402B1 (en) | 2011-08-03 |
| US20090005409A1 (en) | 2009-01-01 |
| PL1784402T3 (pl) | 2011-12-30 |
| WO2006025714A1 (en) | 2006-03-09 |
| JP5126830B2 (ja) | 2013-01-23 |
| AU2005280738B2 (en) | 2010-11-25 |
| MX2007002214A (es) | 2007-05-07 |
| CA2578880C (en) | 2013-01-29 |
| KR20060051002A (ko) | 2006-05-19 |
| CN101018788B (zh) | 2010-08-25 |
| US8148529B2 (en) | 2012-04-03 |
| DK1784402T3 (da) | 2011-11-14 |
| ES2367312T3 (es) | 2011-11-02 |
| BRPI0514843A (pt) | 2008-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8513277B2 (en) | Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof | |
| US10358446B2 (en) | Bruton's tyrosine kinase inhibitors | |
| RU2375359C2 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[3, 2-c]ПИРИДИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| RU2397170C2 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-b]ПИРИДИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| CZ155096A3 (en) | Aminoalkylaminopyridine derivatives, process of their preparation and pharmaceutical composition containing thereof | |
| CA3008653C (en) | Bruton's tyrosine kinase inhibitors | |
| HK1105977B (en) | Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof | |
| EP0680953A1 (en) | 1-[Styryl]- and 1-[2'-(heteroaryl)-ethenyl]-isoquinoline derivatives, a process for preparing them as well as medicaments containing them and the use of them | |
| HK1105976B (en) | Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20170904 |